Pheochromocytoma underlying hypertension, stroke, and dilated cardiomyopathy

Texas Heart Institute Journal

Volumn 34, Issue 2, 2007, Pages 244-246

  Lin, Pi Chi ^a   Hsu, Jen Te ^a   Chung, Chang Min ^a   Chang, Shih Tai ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Adrenal gland neoplasms complications diagnosis pathology; Brain ischemia etiology; Cardiomyopathy, complications dilated etiology; Catecholamines physiology; Cerebrovascular disorders complications; Diagnosis, differential

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ABDOMEN; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE CARDIOMYOPATHY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; HEART DILATATION; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTILITY; HISTORY; HUMAN; HYPERTENSION; MALE; PHEOCHROMOCYTOMA; STROKE; SWEATING; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADRENAL GLAND NEOPLASMS; AGED; CARDIOMYOPATHY, DILATED; CEREBROVASCULAR ACCIDENT; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERTENSION; MALE; PHEOCHROMOCYTOMA; RADIOGRAPHY, THORACIC; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 34447515570     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Sardesai SH, Mourant AJ, Sivathandon Y, Farrow R, Gibbons DO. Phaeochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure. Br Heart J 1990;63:234-7.
2. Wood R, Commerford PJ, Rose AG, Tooke A. Reversible catecholamine-induced cardiomyopathy. Am Heart J 1991;121(2 Pt 1):610-3.
3. Lam JB, Shub C, Sheps SG. Reversible dilatation of hypertrophied left ventricle in pheochromocytoma: serial twodimensional echocardiographic observations. Am Heart J 1985;109(3 Pt 1):613-5.
4. Quigg RJ, Om A. Reversal of severe cardiac systolic dysfunction caused by pheochromocytoma in a heart transplant candidate. J Heart Lung Transplant 1994;13:525-32.
5. Dagartzikas MI, Sprague K, Carter G, Tobias JD. Cerebrovascular event, dilated cardiomyopathy, and pheochromocytoma. Pediatr Emerg Care 2002;18:33-5.
6. Pearce RM. Experimental myocarditis; a study of the histological changes following intravenous injections of adrenalin. J Exp Med 1906;8:400-9.
7. Boutet M, Huttner I, Rona G. Permeability alteration of sarcolemmal membrane in catecholamine-induced cardiac muscle cell injury. In vivo studies with fine structural diffusion tracer horse radish peroxidase. Lab Invest 1976;34:482-8.
8. Bloom S. Catecholamine cardiomyopathy. N Engl J Med 1987;317:900-1.
9. Lehmann FS, Weiss P, Ritz R, Harder F, Staub JJ. Reversible cerebral ischemia in patients with pheochromocytoma. J Endocrinol Invest 1999;22:212-4.
10. Goswami R, Tandon N, Singh B, Kochupillai N. Adrenal tumour, congestive heart failure and hemiparesis in an 18-year-old male. A clinical-pathological conference. Int J Cardiol 1995;49:233-8.
11. Falk RH, Foster E, Coats MH. Ventricular thrombi and thromboembolism in dilated cardiomyopathy: a prospective follow-up study. Am Heart J 1992;123:136-42.
12. Isner JM, Estes NA 3rd, Thompson PD, Costanzo-Nordin MR, Subramanian R, Miller G, et al. Acute cardiac events temporally related to cocaine abuse. N Engl J Med 1986;315:1438-43.
13. Razavi M, Bendixen B, Maley JE, Shoaib M, Zargarian M, Razavi B, Adams HP. CNS pseudovasculitis in a patient with pheochromocytoma. Neurology 1999;52:1088-90.